The recent Robitussin class action settlement has caught the attention of consumers nationwide. Allegations claim that the popular cough medicine, marketed as “non-drowsy,” misled customers by containing dextromethorphan—an ingredient known to cause drowsiness. With a settlement of $4.5 million on the table, affected consumers may be eligible for cash payouts ranging from $1.50 to $4.75 per claim.

This blog post dives deep into the case’s background, outlines the steps to file your claim, and highlights key dates and eligibility requirements. Whether you purchased Robitussin for yourself or your family, understanding these details can help you secure the funds you deserve. Additionally, Sparrow offers a streamlined process to help you file your claim effortlessly. Read on to learn all about the Robitussin class action settlement and how you can benefit.

Detailed Background of the Robitussin Class Action Settlement

The Robitussin class action settlement stems from allegations that the makers of Robitussin falsely marketed certain products as “non-drowsy,” despite containing dextromethorphan—a known sedative. Consumers claim they were misled into believing the products would not affect their alertness, a promise that influenced many purchasing decisions. Two key plaintiffs, Nancy Calchi and Stacey Papalia, filed lawsuits in federal court, alleging that GlaxoSmithKline Consumer Healthcare Holdings (now Haleon) advertised the products deceptively.

The lawsuit argues that the “non-drowsy” label was used in promotional materials and on packaging even though the active ingredient can indeed cause drowsiness. Medical research and internal documents have been cited by the plaintiffs to support their claims. They contend that had they been informed about the potential for drowsiness, they would have chosen alternative products. The case consolidated multiple individual lawsuits and was heard in the U.S. District Court for the Southern District of New York.

Key details of the case include:

• Timeline: The settlement covers purchases made between February 16, 2016, and January 21, 2025.
• Products Involved: A wide range of Robitussin products—syrups, capsules, and gels—that carried the “non-drowsy” label.
• Legal Process: Initially filed in 2022, the lawsuits underwent consolidation, and after several legal maneuvers including appeals and motions, the parties agreed to a $4.5 million settlement.
• Claims: The central claim is that the false advertising led to consumer overcharging, as buyers relied on the “non-drowsy” promise without knowing the truth about the ingredient’s effects.

The settlement does not imply an admission of wrongdoing by Haleon; rather, it serves as a remedy to avoid prolonged litigation and further expenses. Instead of enduring a lengthy trial, the company has opted to resolve the claims by compensating affected consumers on a pro-rata basis. With the agreement in place, eligible consumers can now submit claims to receive a share of the settlement funds. For additional official details and the full settlement terms, you can visit the NonDrowsyRobitussinSettlement.com website.

Who is Eligible For The Robitussin Class Action Settlement

Eligibility for the Robitussin class action settlement is clearly defined. You may be eligible if:

• Purchase History:
  • You purchased any Robitussin product that includes dextromethorphan and was marketed as “non-drowsy.”
  • The purchase was made between February 16, 2016, and January 21, 2025.
• Product Range:
  • Eligible products include a variety of Robitussin items, such as:
    • Robitussin 12-Hour Cough Relief Extended-Release Orange Syrups
    • Robitussin Cough + Chest Congestion DM Maximum Strength Syrups
    • Robitussin Cough + Chest Congestion DM Maximum Strength Liquid-Filled Capsules
    • Robitussin Long-Acting Cough Gels
    • And many more variations as listed on the official settlement site.

• Usage:
  • The claim applies to products purchased for personal or household use, not for resale.
• One Claim Limit Without Proof:
  • If you lack a receipt or other documentation, you can still file one claim per household.

Before filing, review the complete eligibility criteria on the official settlement website to ensure you meet all the necessary conditions.

How Much You Can Receive

The payout for the Robitussin class action settlement depends on the total number of valid claims received. Here are the key points:

• Estimated Payout per Claim:
  • Payouts are estimated to range from $1.50 to $4.75 per claim.
• Filing Multiple Claims:
  • With proof of purchase, you can submit up to three claims per household.
  • Without proof, you are limited to one claim per household.
• Pro Rata Distribution:
  • The total settlement amount of $4.5 million is divided equally among all valid claims.
• Additional Considerations:
  • The exact amount you receive may vary based on the overall number of claims submitted.
  • Legal fees and administrative costs may also affect the final payout.

Consumers should note that even though individual amounts may seem small, every claim contributes to the overall resolution of the false advertising lawsuit. It is an opportunity to recover funds that were lost due to misleading marketing practices.

How to File a Claim

Filing a claim for the Robitussin class action settlement is a straightforward process. Here’s how you can do it:

• Step 1: Check Your Eligibility
  • Confirm you purchased any eligible Robitussin product labeled “non-drowsy.”
  • Ensure the purchase date falls between February 16, 2016, and January 21, 2025.
• Step 2: Gather Your Documentation
  • Collect proof of purchase such as receipts or transaction records.
  • Note that if you do not have proof, you may only file one claim per household.
• Step 3: File Your Claim
  • Visit the official settlement website to submit your claim online.
  • Alternatively, you can use Sparrow which offers an easier, streamlined claim processing option to save you time and hassle.
• Step 4: Submit Before the Deadline
  • Make sure you file your claim by May 12, 2025, to be eligible for a payout.

Each step is designed to ensure a smooth process. Filing online is quick and can be done in a few minutes, allowing you to secure your share of the settlement without unnecessary delays.

Important Deadlines

Staying on top of deadlines is crucial when filing your claim for the Robitussin class action settlement. Key dates include:

• Claim Filing Deadline:
  • May 12, 2025 – Ensure your claim is submitted by this date.
• Exclusion and Objection Deadline:
  • April 14, 2025 – Deadline for any objections or requests for exclusion from the settlement.
• Final Approval Hearing:
  • June 30, 2025 – The final court hearing to approve the settlement. Payouts will be distributed following this hearing and any subsequent appeals.

Mark these dates on your calendar and set reminders so you don’t miss your chance to claim your rightful share of the settlement.

Conclusion

In summary, the Robitussin class action settlement offers a chance for consumers misled by false “non-drowsy” claims to receive compensation. With allegations that Robitussin products contain an ingredient that can cause drowsiness, affected buyers can now file claims to recover funds from a $4.5 million settlement. By following the steps outlined above—checking eligibility, gathering necessary documentation, and filing your claim by the May 12, 2025 deadline—you can participate in this important legal action. For those who prefer a hassle-free experience, usesparrow.com provides a streamlined claim process that takes the stress out of filing. Stay informed, act promptly, and help ensure that your consumer rights are protected. Claim your funds today and share this information with others who might be eligible.

Related articles:

$6 Million Settlement: Zicam Class Action Lawsuit Details And Who Qualifies + How to Claim

$5M La Pura & Konnektive False Advertising Class Action Settlement: What You Need to Know